This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sohn, S. J. Articles by Winoto, A. Search for Related Content PubMed PubMed Citation Articles by Sohn, S. J. Articles by Winoto, A.

Transcriptional Regulation of Tissue-Specific Genes by the ERK5 Mitogen-Activated Protein Kinase

Department of Molecular and Cell Biology, Division of Immunology and Cancer Research Laboratory, University of California, Berkeley, 465 Life Science Addition, Berkeley, California 94720-3200

Received 28 March 2005/ Returned for modification 8 May 2005/ Accepted 7 July 2005

The ERK5 mitogen-activated protein kinase (MAPK) differs from other MAPKs in possessing a potent transcriptional activation domain. ERK5^–/– embryos die from angiogenic defects, but the precise physiological role of ERK5 remains poorly understood. To elucidate molecular functions of ERK5 in the development of vasculature and other tissues, we performed gene profile analyses of erk5^–/– mouse embryos and erk5^–/– fibroblast cells reconstituted with ERK5 or ERK5(1-740), which lacks the transactivation domain. These experiments revealed several potential ERK5 target genes, including a proapoptotic gene bnip3, known angiogenic genes flt1 and lklf (lung Krüppel-like factor), and genes that regulate cardiovascular development. Among these, LKLF, known for its roles in angiogenesis, T-cell quiescence, and survival, was found to be absolutely dependent on ERK5 for expression in endothelial and T cells. We show that ERK5 drives lklf transcription by activating MEF2 transcription factors. Expression of erk5 short hairpin or a dominant-negative form of the ERK5 upstream activator, MEK5, in T cells led to downregulation of LKLF, increased cell size and upregulation of activation markers. Thus, through its kinase and transcriptional activation domains, ERK5 regulates transcriptional responses of cell survival and quiescence critical for angiogenesis and T-cell function.

This article has been cited by other articles:

• Schramp, M., Ying, O., Kim, T. Y., Martin, G. S. (2008). ERK5 promotes Src-induced podosome formation by limiting Rho activation. J. Cell Biol. 181: 1195-1210 [Abstract] [Full Text]  
• Kinderlerer, A. R., Ali, F., Johns, M., Lidington, E. A., Leung, V., Boyle, J. J., Hamdulay, S. S., Evans, P. C., Haskard, D. O., Mason, J. C. (2008). KLF2-dependent, Shear Stress-induced Expression of CD59: A NOVEL CYTOPROTECTIVE MECHANISM AGAINST COMPLEMENT-MEDIATED INJURY IN THE VASCULATURE. J. Biol. Chem. 283: 14636-14644 [Abstract] [Full Text]  
• Fujii, Y., Matsuda, S., Takayama, G., Koyasu, S. (2008). ERK5 is involved in TCR-induced apoptosis through the modification of Nur77.. GENES CELLS 13: 411-419 [Abstract] [Full Text]  
• Atkins, G. B., Jain, M. K. (2007). Role of Kruppel-Like Transcription Factors in Endothelial Biology. Circ. Res. 100: 1686-1695 [Abstract] [Full Text]  
• Nagel, S., Burek, C., Venturini, L., Scherr, M., Quentmeier, H., Meyer, C., Rosenwald, A., Drexler, H. G., MacLeod, R. A. F. (2007). Comprehensive analysis of homeobox genes in Hodgkin lymphoma cell lines identifies dysregulated expression of HOXB9 mediated via ERK5 signaling and BMI1. Blood 109: 3015-3023 [Abstract] [Full Text]  
• Garaude, J., Cherni, S., Kaminski, S., Delepine, E., Chable-Bessia, C., Benkirane, M., Borges, J., Pandiella, A., Iniguez, M. A., Fresno, M., Hipskind, R. A., Villalba, M. (2006). ERK5 Activates NF-{kappa}B in Leukemic T Cells and Is Essential for Their Growth In Vivo. J. Immunol. 177: 7607-7617 [Abstract] [Full Text]  
• Huddleson, J. P., Ahmad, N., Lingrel, J. B. (2006). Up-regulation of the KLF2 Transcription Factor by Fluid Shear Stress Requires Nucleolin. J. Biol. Chem. 281: 15121-15128 [Abstract] [Full Text]